Bereich wird geladen
Kurse um 15 Minuten verzögert
Die Reihe ist auf die aktuelle Aktienzahl nach Splits umgerechnet; Dividenden sind nicht im Kurs enthalten
| Datum | Eröffnung | Hoch | Tief | Schluss | Volumen, Stück |
|---|---|---|---|---|---|
| 16. September 2026 | 150,34 | 151,31 | 149,00 | 149,50 | 1 Mio. |
| 15. September 2026 | 156,70 | 156,70 | 149,15 | 150,02 | 1 Mio. |
| 14. September 2026 | 158,00 | 159,19 | 156,57 | 157,22 | 785.500 |
| 11. September 2026 | 157,20 | 159,67 |
Auf Basis der Berichte bis 31. Dezember 2025
Neurocrine treats neurological and hormonal disorders — above all involuntary movements caused by antipsychotics.
The main drug relieves involuntary movements that develop in some patients after long use of psychiatric medication. The condition is persistent, the course of treatment long, and alternatives few — hence steady recurring revenue.
The disorder is under-diagnosed: a general practitioner does not always recognise it, so growth depends on educating psychiatrists as much as on the drug itself. The second line is congenital adrenal hyperplasia, where a new medicine allows hormone doses to be reduced. Risks: the patent term, competition and insurer decisions. Development continues in psychiatry, where the pipeline is the main source of value beyond the current drug. The company pays no dividend.
Adresse:6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130, US
| 359 Mio. |
| TWSTTwist Bioscience Corporation | 155,56 | +8,73 % | 226 Mio. |
| HALOHalozyme Therapeutics, Inc. | 109,72 | +1,18 % | 211 Mio. |
| TECHBio-Techne Corp | 72,41 | +0,11 % | 192 Mio. |
| RGENRepligen Corporation | 178,19 | +3,05 % | 165 Mio. |
| 156,12 |
| 156,22 |
| 890.900 |
| 10. September 2026 | 154,38 | 159,94 | 152,04 | 156,57 | 895.200 |
| 09. September 2026 | 154,61 | 155,55 | 152,38 | 155,14 | 1 Mio. |
| 08. September 2026 | 153,99 | 156,82 | 151,77 | 155,13 | 818.700 |
| 04. September 2026 | 158,24 | 159,80 | 154,83 | 155,64 | 933.400 |
| 03. September 2026 | 159,93 | 159,93 | 156,76 | 158,35 | 758.300 |
| 02. September 2026 | 157,39 | 160,43 | 155,09 | 157,79 | 1 Mio. |
| 01. September 2026 | 154,31 | 157,03 | 153,70 | 156,76 | 878.400 |
| 31. August 2026 | 153,11 | 155,00 | 151,77 | 154,03 | 2 Mio. |
| 28. August 2026 | 155,92 | 156,57 | 153,08 | 154,06 | 813.000 |
| 27. August 2026 | 155,28 | 156,75 | 154,61 | 155,92 | 730.300 |
| 26. August 2026 | 153,21 | 159,40 | 152,02 | 156,59 | 1 Mio. |
| 25. August 2026 | 153,84 | 156,13 | 152,01 | 153,37 | 1 Mio. |
| 24. August 2026 | 152,57 | 154,56 | 151,77 | 153,04 | 1 Mio. |
| 21. August 2026 | 153,13 | 155,27 | 152,51 | 152,57 | 1 Mio. |
| 20. August 2026 | 154,99 | 155,81 | 152,50 | 152,93 | 870.700 |
| 19. August 2026 | 156,56 | 156,56 | 154,34 | 155,54 | 1 Mio. |